8-(2-Hydroxy-3-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)propoxy)-7-methoxy-3-methylisochroman-4-one

ID: ALA4533900

Chembl Id: CHEMBL4533900

PubChem CID: 155546966

Max Phase: Preclinical

Molecular Formula: C23H32N2O7

Molecular Weight: 448.52

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1OCC(O)CN1CCN(C(=O)C3CCCO3)CC1)COC(C)C2=O

Standard InChI:  InChI=1S/C23H32N2O7/c1-15-21(27)17-5-6-19(29-2)22(18(17)14-31-15)32-13-16(26)12-24-7-9-25(10-8-24)23(28)20-4-3-11-30-20/h5-6,15-16,20,26H,3-4,7-14H2,1-2H3

Standard InChI Key:  RDIPRMMTCLDOEU-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4533900

    ---

Associated Targets(non-human)

Thoracic aorta (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1d Alpha-1d adrenergic receptor (1475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 448.52Molecular Weight (Monoisotopic): 448.2210AlogP: 0.86#Rotatable Bonds: 7
Polar Surface Area: 97.77Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.60CX LogP: 0.27CX LogD: 0.26
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.66Np Likeness Score: -0.32

References

1. Xie S, Li X, Yu H, Zhang P, Wang J, Wang C, Xu S, Wu Z, Liu J, Zhu Z, Xu J..  (2019)  Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidates.,  27  (13): [PMID:31078380] [10.1016/j.bmc.2019.05.004]

Source